Search Results - "Bonaso, Marco"

Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy by Convertino, Irma, Cazzato, Massimiliano, Tillati, Silvia, Giometto, Sabrina, Gini, Rosa, Valdiserra, Giulia, Cappello, Emiliano, Ferraro, Sara, Bonaso, Marco, Bartolini, Claudia, Paoletti, Olga, Lorenzoni, Valentina, Trieste, Leopoldo, Filippi, Matteo, Turchetti, Giuseppe, Cristofano, Michele, Blandizzi, Corrado, Mosca, Marta, Lucenteforte, Ersilia, Tuccori, Marco

“…Introduction: The disease activity associated with the drug-utilization patterns of biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) is poorly…”
Get full text

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis by Convertino, Irma, Lorenzoni, Valentina, Gini, Rosa, Turchetti, Giuseppe, Fini, Elisabetta, Giometto, Sabrina, Bartolini, Claudia, Paoletti, Olga, Ferraro, Sara, Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Blandizzi, Corrado, Tuccori, Marco, Lucenteforte, Ersilia

“…This study is aimed at describing tofacitinib and baricitinib users by characterizing their prescription and healthcare histories, drug and healthcare…”
Get full text

A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy by da Silva Machado, Fernanda Lacerda, Cañás, Martín, Urtasun, Martín A, Marín, Gustavo H, Albuquerque, Flavia Caixeta, Pont, Lisa, Convertino, Irma, Bonaso, Marco, Tuccori, Marco, Kirchmayer, Ursula, Lopes, Luciane Cruz

“…Biosimilar medicines are defined as biological products highly similar to an already licensed biological product (RP). The market entry of biosimilars is…”
Get more information

Cohort event monitoring of safety of COVID-19 vaccines: the Italian experience of the “ilmiovaccinoCOVID19 collaborating group” by Luxi, Nicoletta, Bellitto, Chiara, Ciccimarra, Francesco, Cappello, Emiliano, L’Abbate, Luca, Bonaso, Marco, Ajolfi, Chiara, Baldo, Paolo, Bonaiuti, Roberto, Costantino, Claudio, De Sarro, Giovambattista, Di Mauro, Cristina, Fava, Giuseppina, Ferri, Marina, Firenze, Alberto, Furci, Fabiana, Gallelli, Luca, Leonardi, Luca, Negri, Giovanna, Pieraccini, Fabio, Poluzzi, Elisabetta, Sacripanti, Chiara, Sangiorgi, Elisa, Sapigni, Ester, Senesi, Ilenia, Tessari, Roberto, Trabace, Luigia, Vannacci, Alfredo, Venturini, Francesca, Vitale, Francesco, Zodda, Donatella, Tuccori, Marco, Trifirò, Gianluca

“…Introduction: In 2021, the European Medicines Agency supported the “Covid Vaccine Monitor (CVM),” an active surveillance project spanning 13 European countries…”
Get full text

Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database by Ferraro, Sara, Cappello, Emiliano, Fornili, Marco, Convertino, Irma, Bonaso, Marco, Lucenteforte, Ersilia, Tuccori, Marco

Get full text

Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review by Franchini, Massimo, Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Moretti, Ugo, Focosi, Daniele, Tuccori, Marco

“…Acquired hemophilia A (AHA), a rare but life-threatening disorder, most commonly occurs in older people and during pregnancy. During the coronavirus disease…”
Get more information

Comment on: “Deliberate Self-Poisoning: Real-Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System” by Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Ferraro, Sara, Convertino, Irma, Tuccori, Marco

Get full text

Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option by Ferraro, Sara, Convertino, Irma, Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Tuccori, Marco

“…The COVID-19 pandemic stimulated the development of several therapeutic tools with several degrees of success. Ensitrelvir, a protease inhibitor that blocks…”
Get more information

Comment on: "Deliberate Self‑Poisoning: Real‑Time Characterisation of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System" / Reply by Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Ferraro, Sara, Convertino, Irma, Tuccori, Marco, Fusaroli, Michele, Pelletti, Guido, Giunchi, Valentina, Raschi, Emanuel, De Ponti, Fabrizio, Pelotti, Susi, Poluzzi, Elisabetta

Get full text

Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence by Convertino, Irma, Ferraro, Sara, Cappello, Emiliano, Valdiserra, Giulia, Bonaso, Marco, Tuccori, Marco

“…Direct-acting SARS-CoV-2 antiviral monoclonal antibodies have been an integral part of therapeutic strategies against COVID-19 pandemic. The monoclonal…”
Get more information

Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison by Machado, Fernanda Lacerda da Silva, Cañás, Martín, Doubova, Svetlana V., Urtasun, Martín A., Marín, Gustavo H., Osorio-de-Castro, Claudia Garcia Serpa, Albuquerque, Flavia Caixeta, Ribeiro, Tatiane Bonfim, Pont, Lisa, Crisóstomo Landeros, José, Roldán Saelzer, Juan, Sepúlveda Viveros, Dino, Acosta, Angela, Machado Beltrán, Manuel A., Gordillo Alas, Lily Iracema, Orellana Tablas, Lourdes Abigail, Benko, Ria, Convertino, Irma, Bonaso, Marco, Tuccori, Marco, Kirchmayer, Ursula, Contreras Sánchez, Saúl E., Rodríguez-Tanta, L. Yesenia, Gutierrez Aures, Ysabel, Lin, Boya, Alipour-Haris, Golnoosh, Eworuke, Efe, Lopes, Luciane Cruz

“…Biosimilars are biological medicines highly similar to a previously licensed reference product and their licensing is expected to improve access to biological…”
Get full text

Signal management and risk minimization strategy: a case study on obinutuzumab and non-overt disseminated intravascular coagulation by Valdiserra, Giulia, Mores, Nadia, Rocchi, Rosalba Elisabetta, Sottosanti, Laura, Felicetti, Patrizia, Marchione, Pasquale, Laurenti, Luca, Fresa, Alberto, Bucaneve, Giampaolo, Cappello, Emiliano, Bonaso, Marco, Ferraro, Sara, Convertino, Irma, Tuccori, Marco

“…Introduction: In December 2020, the Italian Medicines Agency (AIFA) in collaboration with the Italian Regional Centers of Pharmacovigilance evaluated four…”
Get full text